ImpediMed Limited (ASX:IPD)

ImpediMed Revenue

In the fiscal year ending June 30, 2026, ImpediMed had annual revenue of 14.61M AUD with 14.85% growth. ImpediMed had revenue of 7.10M in the half year ending June 30, 2026, with 28.22% growth.

• Revenue: 14.61M
• Revenue Growth: +14.85%
• P/S Ratio: 1.25
• Revenue / Employee: 221.41K
• Employees: 66
• Market Cap: 18.31M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2026	14.61M	1.89M	14.85%
Jun 30, 2025	12.72M	2.41M	23.31%
Jun 30, 2024	10.32M	-1.03M	-9.04%
Jun 30, 2023	11.34M	778.00K	7.36%
Jun 30, 2022	10.57M	2.16M	25.65%

Data Source: S&P Global Market Intelligence Last updated: Aug 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 14, 2026

Data Sources Report a data error